Human apolipoprotein A-I forms small high density lipoprotein particles in rats in vivo.
The effects of injection of purified human or rat apolipoprotein (apo) A-I (1.7 mg/100 g body weight) on the size and composition of rat high density lipoprotein (HDL) particles have been investigated. The injection of human apo A-I results in the formation (over a period of 3 to 6 h) of a population of smaller HDL particles resembling human HDL3. This population of smaller particles contains human apo A-I and rat apo A-IV but lacks rat apo A-I and rat apo E. Small HDL3-like particles are not detected in rat plasma following the injection of rat apo A-I. Associated with the injection of either human or rat apo A-I is a gradual increase of plasma cholesterol levels of 20 to 50% (over 24 h) and the appearance of larger HDL particles. The results suggest that the smaller HDL particles in human plasma compared to rat plasma are not simply due to the action of lipid modifying enzymes or lipid transfer proteins but a specific property of human apo A-I.
Ha
Y C
YC
Russell Grimwade School of Biochemistry, University of Melbourne, Parkville, Australia.
Trifunovic
Z
Z
Howlett
G J
GJ
D000818:Animals; D016632:Apolipoprotein A-I / Q000008:administration & dosage / Q000737:chemistry*; D001053:Apolipoproteins / Q000097:blood / Q000737:chemistry; D002784:Cholesterol / Q000097:blood; D006801:Humans; D007269:Injections, Intra-Arterial; D008075:Lipoproteins, HDL / Q000097:blood* / Q000737:chemistry; D008297:Male; D010316:Particle Size; D051381:Rats; D011915:Rats, Inbred BUF; D013045:Species Specificity; D014280:Triglycerides / Q000097:blood
D016632:Apolipoprotein A-I; D001053:Apolipoproteins; D008075:Lipoproteins, HDL; D014280:Triglycerides; D002784:Cholesterol